Posted by Flash (217.32.162.242) on February 27, 2001 at 14:13:45:
Craig,
This is an impressive report. I am forwarding it to psychiatrists who are
involved in psilocybin research. I see you have already contacted MAPS, who
has been working with a neurologist who is trying to do research treating
migraines with marijuana. The fact that you are in contact with a CH expert
is most important. I think a first step, if it has not already happened, is
to have a CH specialist publish your case and the cases of others in
neurological or headache journals, to spread the word and to generate
interest in research in the subject.
Any research projecton this treatment, such as a small pilot study, would
best be done by a neurologist who specializes in CH and is on the faculty of
a medical school. The Heffter Institute would welcome any such research
proposal and would seriously consider it for funding once it was approved by
the FDA. We would have to raise the money, though, and our funds are fully
committed at this time. However, with an FDA-approved proposal, I am
betting that the money could be raised within the community of CH patients
and others interested in medical applications of hallucinogens.
I would be happy to work with any medical school neurologists on this. We
work with researchers who have gone through the FDA process with
hallucinogens and can advise them on the process.
George Greer, M.D.
Medical Director
Heffter Research Institute